Medical Device News Magazine

Sleepiz Joins American Telemedicine Association: Reports Expansion Progress

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Three months ago, FDA approval paved the way for MedTech startup Sleepiz to enter the US market with its remote patient monitoring device, now the company is already reporting expansion progress and joining the largest US organization for telemedicine.

It was only in July that the Swiss MedTech startup registered its Sleepiz One+ device for contactless measurement of breathing and heart rate with the US Food and Drug Administration (FDA) and announced its expansion into the US. Now Sleepiz is joining the American Telemedicine Association (ATA). Membership gives the company access to a broad network of tech providers, investors, health institutions, industry experts and policy makers.

Three months after expanding into the U.S., Sleepiz joins the ATA – a broad network of leading healthcare delivery systems, academic institutions, technology solution providers and payers, committed to advancing telehealth in the United States. Founded in 1993 and with more than 400 members, the organization is committed to ensuring that everyone has access to safe, affordable, and appropriate care when and where they need it.

“Membership with the ATA gives us the opportunity to raise awareness of Sleepiz’s technology in U.S. and global markets,” said Robb LaChappelle, Sleepiz’s vice-president in the United States. Sleepiz CEO Soumya Dash said, “This is an important step in bringing the benefits of our technology to patients, physicians and researchers, expanding the company’s success into foreign markets.”

Sleepiz One+ provides new insights into patient health status

Sleepiz One+ is one of the first respiratory monitoring devices to contactlessly capture and record patient data during sleep. The technology provides entirely new insights into patient health, as physicians no longer have to rely on random measurements, but gain access to continuous data. Physicians in the U.S. can prescribe Sleepiz One+ to their patients to measure their vital signs in the short and long term, providing greater insight into patients’ physiological status. For patients, Sleepiz One+ provides a new and convenient way to take continuous measurements at home by simply placing a small device on their bedside table before bed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”